PFE
Pfizer (NYSE: PFE) faced headlines highlighting growing concerns about U.
Article Summary
SELL- Pfizer (NYSE: PFE) faced headlines highlighting growing concerns about U.S. reliance on Chinese biotechs, prompting concerns about national security implications.
- The company's reliance on China-based pharmaceuticals has raised concerns about potential national-security implications.
- Pfizerâ€and its ability to compete in a global market with cheaper, more efficient alternativesâ€ŝwas cited as a key factor in the controversy.
- Investors and lawmakers are weighing whether Pfizer may face increased regulatory pressure if reliance continues to grow.
- While Pfizer remains a major US drugmaker, the news highlights broader concerns about reliance on foreign-based biotechs.
Free users see 3 BUY signals per day. Premium unlocks all of them, plus instant email alerts.
See Plans
Growth Stock Scoring Breakdown
| METRIC | VALUE | WEIGHT | ANALYSIS |
|---|---|---|---|
| Sales Growth TTM ? | 1.4% | 25% | 20.0 ptsMinimal (1.4%) - Very weak |
| EPS Growth Next 5Y ? | -8.9% | 25% | 0.0 ptsNegative (-8.9%) - Declining expectations |
| Target Price Upside ? | 10.5% | 20% | 50.0 ptsMeets Minimum (10.5%) - Target: $28.92 vs Current: $26.18 |
| Gross Margin % ? | 65.2% | 15% | 80.0 ptsVery Healthy (65.2%) - High-quality margins |
| Drawdown from 52-Wk High ? | -8.9% | 15% | 20.0 ptsBarely a Dip (-8.9%) - Near recent highs |
Disclaimer: This rating is for informational purposes only and is not financial advice.
All data sourced from Finviz.
Always conduct your own research and consult with a financial advisor before making investment decisions.
Past performance does not guarantee future results.
About PFE
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
- It operates in three segments: Biopharma, PC1, and Pfizer Ignite.
- The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19.
- It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands.
- In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands.
- Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin.
- The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models.
- Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.